Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis (Q73428319)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

A Inoue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H Kunitoh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

I Sekine

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Sumi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Tokuuye

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Saijo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

649-655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Combined modality therapy for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a So

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900783-5

7 January 2021

10.1016/S0360-3016(00)00783-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172945%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference